Maze Therapeutics, Inc. , a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.
Maze Therapeutics stock last closed at $13.40, down 1.11% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Maze Therapeutics stock is currently +99.7% from its 52-week low of $6.71, and -21.18% from its 52-week high of $17.00.
As of Jun 13, 2025, there are 43.8M MAZE shares outstanding. The market value of MAZE is $586.88M. In the last 24 hours, 101,000 MAZE shares were traded.
You need a brokerage account to access the NASDAQ market and buy MAZE shares.
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected your brokerage, you need to fill out some personal information so you are able to buy MAZE stock today.
Now that you've finished signing up on one of the best stock trading apps, you can securely and quickly fund your account:
Check out the walkthrough below to see the process of depositing money into your brokerage account.
Once you have figured out the best place to buy Maze Therapeutics stock, it's critical to evaluate their stock prior to investing, so you actually comprehend the risk as well as the upside.
WallStreetZen was built to help average investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on MAZE's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge MAZE's intrinsic value.
Using relative valuations ratios:
You can do more valuation analysis on MAZE's stock here.
Out of 3 sell side analysts who track MAZE, the consensus analyst rating on MAZE is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Maze Therapeutics stock forecast page.
In the last 12 months, executives and large shareholders at MAZE have not bought or sold any shares.
Get more info about who owns MAZE stock here.
No, Maze Therapeutics doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two primary options:
Click the Open Trade button and eToro will place the order.
If you need more help investing in stocks on eToro, click the how to video below:
Now that you own some MAZE stock, you'll want to stay up-to-date on your company.
Put MAZE on a watchlist to get the latest updates about your MAZE stock.
To reiterate, here are the 6 steps to buy Maze Therapeutics stock:
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to watch your investment in Maze Therapeutics, hit the button below to create your watchlist.